MSD Of India Defends Marketing Of Gardasil Against Cervical Cancer
This article was originally published in PharmAsia News
Executive Summary
India's MSD Pharmaceuticals Private says its marketing of Gardasil vaccine, approved to prevent the human papilloma virus, for other uses is justified given 10 years of research and development